Medicinova Inc (MNOV): Cash & Equivalents
$30.81M
As of 2025-12-31
$25.42M
As of 2026-06-30
+18.5%
3-year compound annual growth
-12.5%
5-year compound annual growth
+3.4%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $30.81M | -23.7% | 2026-03-10, Balance as of period end |
| 2024-12-31 | $40.36M | -20.9% | 2026-03-10, Balance as of period end |
| 2023-12-31 | $51.00M | +175.6% | 2025-02-19, Balance as of period end |
| 2022-12-31 | $18.51M | -74.1% | 2024-02-15, Balance as of period end |
| 2021-12-31 | $71.43M | +19.0% | 2023-03-28, Balance as of period end |
| 2020-12-31 | $60.04M | -5.9% | 2022-02-16, Balance as of period end |
| 2019-12-31 | $63.79M | +2.4% | 2021-02-19, Balance as of period end |
| 2018-12-31 | $62.31M | +122.6% | 2020-02-13, Balance as of period end |
| 2017-12-31 | $27.99M | +16.1% | 2019-02-13, Balance as of period end |
| 2016-12-31 | $24.12M | +9.2% | 2019-02-13, Balance as of period end |
| 2015-12-31 | $22.08M | +89.2% | 2018-02-13, Balance as of period end |
| 2014-12-31 | $11.67M | +74.2% | 2017-02-14, Balance as of period end |
| 2013-12-31 | $6.70M | +67.1% | 2015-03-12, Balance as of period end |
| 2012-12-31 | $4.01M | -73.4% | 2014-03-27, Balance as of period end |
| 2011-12-31 | $15.09M | -46.6% | 2013-03-28, Balance as of period end |
| 2010-12-31 | $28.25M | +46.8% | 2013-03-28, Balance as of period end |
| 2009-12-31 | $19.24M | -0.3% | 2012-03-29, Balance as of period end |
| 2008-12-31 | $19.30M | n/a | 2012-03-29, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Medicinova Inc (MNOV) | 2025-12-31 | $30.81M | -23.7% |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | $5.53M | +14.6% |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | $6.66M | n/a |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | $251.3K | -18.3% |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $40.99M | -41.3% |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $14.69M | -24.8% |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $4.98M | n/m |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $2.18M | -33.7% |
| Silence Therapeutics plc (SLN) | 2025-12-31 | $11.28M | -90.7% |
Compare MNOV, CANF, SCNX, PVCT side by side · Screen every company in Pharmaceutical Preparations ↗